Agilon Health Inc (NYSE:AGL) price on Thursday, March 20, fall -6.82% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.10.
A look at the stock’s price movement, the close in the last trading session was $4.40, moving within a range at $4.05 and $4.36. The beta value (5-Year monthly) was 0.677. Turning to its 52-week performance, $7.73 and $1.50 were the 52-week high and 52-week low respectively. Overall, AGL moved 14.85% over the past month.
Agilon Health Inc’s market cap currently stands at around $1.69 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Analysts have a consensus estimate of 1.5B for the company’s revenue for the quarter, with a low and high estimate of 1.49B and 1.54B respectively. The average forecast suggests down to a -6.23% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 5.99B, representing a -1.15% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AGL is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 7 recommend AGL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AGL’s current price about 11.14% and 19.62% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 62.04, while 7-day volatility ratio is 6.29% and 9.66% in the 30-day chart. Further, Agilon Health Inc (AGL) has a beta value of 0.42, and an average true range (ATR) of 0.30. Analysts have given the company’s stock an average 52-week price target of $2.75, forecast between a low of $2.5 and high of $3. Looking at the price targets, the low is 39.02% off current price level while to achieve the yearly target high, price needs to move 26.83%. Nonetheless, investors will most likely welcome a 32.93% jump to $2.75 which is the analysts’ median price.
If we refocus on Agilon Health Inc (NYSE:AGL), historical trading data shows that trading volumes averaged 6.39 over the past 10 days and 5.45 million over the past 3 months. The company’s latest data on shares outstanding shows there are 412.19 million shares.
The 26.37% of Agilon Health Inc’s shares are in the hands of company insiders while institutional holders own 71.68% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 16.82 million on 2025-02-28, giving us a short ratio of 2.91. The data shows that as of 2025-02-28 short interest in Agilon Health Inc (AGL) stood at 1610.0000000000002 of shares outstanding, with shares short falling to 20.24 million registered in 2025-01-31. Current price change has pushed the stock 115.79% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AGL stock continues to rise going into the next quarter.
